Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 0 | 0 | 500 | 0 | 0 |
| Gross Profit | N/A | N/A | 500 | N/A | 0 |
| Operating Expenses | 26,928 | 21,405 | 19,807 | 18,647 | 21,939 |
| Operating Income | -26,928 | -21,405 | -19,307 | -18,647 | -21,939 |
| Other Income | 293 | 361 | 378 | 230 | 189 |
| Pre-tax Income | -26,635 | -21,044 | -18,929 | -18,417 | -21,749 |
| Net Income Continuous | -26,635 | -21,044 | -18,929 | -18,417 | -21,749 |
| Net Income | $-26,635 | $-21,044 | $-18,929 | $-18,417 | $-21,749 |
| EPS Basic Total Ops | -0.91 | -0.73 | -0.66 | -0.69 | -0.93 |
| EPS Basic Continuous Ops | -0.92 | -0.73 | -0.66 | -0.69 | -0.93 |
| EPS Diluted Total Ops | -0.91 | -0.73 | -0.66 | -0.69 | -0.93 |
| EPS Diluted Continuous Ops | -0.92 | -0.73 | -0.66 | -0.69 | -0.93 |
| EPS Diluted Before Non-Recurring Items | -0.92 | -0.73 | -0.66 | N/A | N/A |
| EBITDA(a) | $-26,951 | $-21,440 | $-19,298 | $-18,638 | $-21,906 |